Leuprolide 2WK 14 MG/2.8 ML KTS
Ended Awarded Last action
- Contract number
- SPE2DR26FZ92Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,759
Award facts
- Contract value 100% obligated
- $2,758.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,758.82 to AmerisourceBergen Drug Corp for Leuprolide 2-week 14 mg/2.8 ml kits on December 10, 2025, with an ultimate completion date of December 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location in Conshohocken, PA 19428. Leuprolide is a hormone therapy medication commonly used in military and federal healthcare systems for treating hormone-responsive conditions.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract reflects AmerisourceBergen's established capability to fulfill federal medical procurement requirements through competitive bidding and serves as part of DLA's broader pharmaceutical supply chain supporting Department of Defense medical operations.
Quick answers
Who was awarded contract SPE2DR26FZ92Y?
SPE2DR26FZ92Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FZ92Y worth?
The government has obligated $2,759 on SPE2DR26FZ92Y.
Is contract SPE2DR26FZ92Y an order under another contract?
Yes. SPE2DR26FZ92Y is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ92Y competed?
The extent of competition for SPE2DR26FZ92Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award